A Study to Assess the Ability of a Novel Endocrine Treatment for Breast Cancer, Irosustat, to Slow Down Cancer Growth
Clinical trial NCT01662726 · TERMINATED
Trial details
- NCT number
- NCT01662726
- Sponsor
- Imperial College London
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2014-07-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.